May 15, 2020 Roth Capital Partners Acts as Co-Manager for Compass Diversified Holdings (NYSE: CODI) in its $88 million Follow-On Roth Capital Partners
May 14, 2020 Roth Capital Partners Acts as Sole Book-Running Manager for Delcath Systems, Inc. (NASDAQ: DCTH) in its $22 Million Follow-On Roth Capital Partners
May 7, 2020 Roth Capital Partners Acts as Sole Placement Agent for Tellurian, Inc. (NASDAQ: TELL) in its $56 Million Registered Direct Note Offering Roth Capital Partners
May 6, 2020 Roth Capital Partners Acts as Sole Placement Agent for Immunic, Inc. (Nasdaq: IMUX) in its $15 Million Registered Direct Roth Capital Partners
May 5, 2020 Roth Capital Partners Acts as Lead Placement Agent for Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) In its $20 Million Follow-On Roth Capital Partners
May 4, 2020 Roth Capital Partners Acts as Co-Manager for Arcturus Therapeutics Holdings, Inc. (NASDAQ: ARCT) in its $80.5 Million Follow-On Roth Capital Partners
Apr 24, 2020 Roth Capital Partners Acts as Sole Manager for Reed’s Inc. (Nasdaq: REED) in its $5.8 Million Follow-On Roth Capital Partners
Apr 23, 2020 Roth Capital Partners Acts as Co-Manager for Crinetics Pharmaceuticals (Nasdaq: CRNX) in its $115.1 Million Follow-On Roth Capital Partners
Apr 20, 2020 Roth Capital Partners Acts as Lead Manager for Bionano Genomics (NASDAQ: BNGO) in its $18 Million Follow-On Roth Capital Partners
Apr 16, 2020 Roth Capital Partners acts as Financial Advisor to Boardriders on its sale of Xcel to ZG Holdings Roth Capital Partners
